AbbVie (ABBV) Retained Earnings (2012 - 2026)

AbbVie (ABBV) has reported Retained Earnings for 15 consecutive years, with -$17.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings fell 50.68% year-over-year to -$17.3 billion in Q2 2026; TTM through Jun 2026 was -$17.3 billion, a 50.68% decrease from a year earlier, with the FY2025 full-year figure at -$15.5 billion, down 96.11% from the prior year.
• Retained Earnings was -$17.3 billion for Q2 2026 at AbbVie, up from -$17.9 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $5.1 billion in Q1 2022 and troughed at -$17.9 billion in Q1 2026.
• A 5-year average of -$5.1 billion and a median of -$3.1 billion in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings jumped 256.94% in 2022 and sank 288.22% in 2025, its largest moves.
• Over 5 years, Retained Earnings stood at $4.8 billion in 2022, then slumped by 148.18% to -$2.3 billion in 2023, then sank by 242.73% to -$7.9 billion in 2024, then plunged by 96.11% to -$15.5 billion in 2025, then fell by 11.88% to -$17.3 billion in 2026.
• The last three Retained Earnings figures came in at -$17.3 billion (Q2 2026), -$17.9 billion (Q1 2026), and -$15.5 billion (Q4 2025), per Business Quant data.